![Motoki Nakai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Motoki Nakai first degree
Entity | Entity type | Industry | |
---|---|---|---|
Curreio, Inc.
![]() Curreio, Inc. Pharmaceuticals: MajorHealth Technology Curreio, Inc. is a drug discovery startup company founded in August 2019 and based in Tokyo, Japan. The Japanese company specializes in cryo-EM structural analysis technology and has unique technologies and know-how in protein production and purification, grid preparation, and 3D structural analysis. Curreio is currently developing internal/collaborative drug discovery projects and drug discovery support services for pharmaceutical companies using their cryo-EM technologies. The company's goal is to expand the possibilities of drug discovery for challenging proteins and protein-supramolecular complexes through structural analysis. The CEO is Motoki Nakai.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Motoki Nakai via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MODALIS THERAPEUTICS CORPORATION | Biotechnology | Founder | |
University of Tokyo | College/University | Corporate Officer/Principal |
Statistics
International
Japan | 3 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Operational
Director/Board Member | 2 |
Founder | 1 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Most connected contacts
Insiders | |
---|---|
Osamu Nureki | 3 |
- Stock Market
- Insiders
- Motoki Nakai
- Company connections